GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo

We have previously demonstrated that estrogen receptor (ER) alpha (ESR1) increases proliferation of adrenocortical carcinoma (ACC) through both an estrogen-dependent and -independent (induced by IGF-II/IGF1R pathways) manner. Then, the use of tamoxifen, a selective estrogen receptor modulator (SERM)...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Chimento, Adele, Sirianni, Rosa, Casaburi, Ivan, Zolea, Fabiana, Rizza, Pietro, Avena, Paola, Malivindi, Rocco, De Luca, Arianna, Campana, Carmela, Martire, Emilia, Domanico, Francesco, Fallo, Francesco, Carpinelli, Giulia, Cerquetti, Lidia, Amendola, Donatella, Stigliano, Antonio, Pezzi, Vincenzo
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2015
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4662484/
https://ncbi.nlm.nih.gov/pubmed/26131713
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki